{
  "drug_name": "Atovaquone",
  "url": "https://wikem.org/wiki/Atovaquone",
  "scraped_at": "2026-01-10T07:48:19.225455",
  "sections": {
    "Administration": {
      "text": "Type: Antimicrobial (active against\nPneumocystis jirovecii\n,\nBabesiosis\n,\nToxoplasmosis\n,\nMalaria\n)\nDosage Forms: tablet, oral suspion\nDosage Strengths: tablet: 250mg; oral suspension: 750mg/5mL\nRoutes of Administration: PO\nCommon Trade Names: Mepron",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pneumocystis jirovecii",
          "url": "https://wikem.org/wiki/Pneumocystis_jirovecii"
        },
        {
          "text": "Babesiosis",
          "url": "https://wikem.org/wiki/Babesiosis"
        },
        {
          "text": "Toxoplasmosis",
          "url": "https://wikem.org/wiki/Toxoplasmosis"
        },
        {
          "text": "Malaria",
          "url": "https://wikem.org/wiki/Malaria"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "Babesiosis: 750mg PO q12h + azithromycin\nToxoplasma encephalitis, HIV+: 1500mg daily + leucovorin +/- pyrimethamine\nPCP pneumonia (2nd line): 1500mg daily\nMalaria prophylaxis:",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "Babesiosis: 20mg/kg q12h (max 750mg/dose) + azithromycin\nPCP pneumonia (2nd line)\n>13yo,  HIV-Â : 1500mg daily\nAdolescents, HIV+: 1500mg daily +/- leucovorin, +/- pyrimethamine\n1-3mo, 2-13yo, HIV+: 30 mg/kg PO daily\n4-24mo, HIV+: 45mg/kg PO daily\nMalaria prophylaxis: 250mg + 100mg proguanil daily\nMalaria falciparum/vivax treatment: 1000mg + proguanil 400mg daily",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C\nLactation risk\n: Infant risk cannot be ruled out\nRenal dosing: atovaquone/proguanil contraindicated in severe renal failure for malaria prophylaxis, otherwise no adjustment\nHepatic dosing: no adjustment",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "SJS, erythema multiforme\nMethemoglobinemia\nHepatitis, liver failure",
          "tables": []
        },
        "Common": {
          "text": "Nausea/vomiting, diarrhea\nRash\nHeadache, insomnia\nFever\nCough, rhinitis",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "SJS, erythema multiforme\nMethemoglobinemia\nHepatitis, liver failure",
      "subsections": {
        "Common": {
          "text": "Nausea/vomiting, diarrhea\nRash\nHeadache, insomnia\nFever\nCough, rhinitis",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Nausea/vomiting, diarrhea\nRash\nHeadache, insomnia\nFever\nCough, rhinitis",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 2.2-3.2 days\nMetabolism: undergoes enterohepatic recirculation\nExcretion: Fecal",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Unclear mechanism; structurally similar to ubiquonone, which inhibits cytochromal electron transport in Plasmodia species",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}